Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

NC-2500 is selected for clinical development in gout-related hyperuricemia

Sep. 7, 2010

PET ligand [11C]-AZ-10419369 is sensitive to changes in brain serotonin levels in vivo

Sep. 7, 2010

ARRY-470 shows promising analgesic activity in vivo

Sep. 7, 2010

AZ-889 shows potent antinociceptive activity in vivo

Sep. 7, 2010

DHMEQ promotes allograft survival and attenuates diabetes in preclinical studies

Sep. 7, 2010

Studies evaluate tamsulosin and doxazosin for urolithiasis

Sep. 6, 2010

Amgen discloses new selective inhibitors of hepatocyte growth factor receptor

Sep. 6, 2010

Atopaxar may reduce major cardiac events in subjects with ACS and CAD

Sep. 6, 2010

AstraZeneca's new TRPV1 antagonists inhibit capsaicin-evoked pain and flare

Sep. 6, 2010

French scientists identify NTNG1 gene polymorphisms linked to alcohol and cocaine codependence

Sep. 6, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.